Why Is the Liposomal Irinotecan Market Growing?
Liposomal irinotecan is a chemotherapy agent formulated in liposomes to improve delivery and reduce toxicity. It is used primarily in pancreatic cancer and other solid tumors. The global liposomal irinotecan market is growing as cancer prevalence rises and demand for better-tolerated therapies increases. The liposomal irinotecan market is driven by the rising incidence of pancreatic cancer,...
0 Σχόλια 0 Μοιράστηκε 292 Views 0 Προεπισκόπηση